1979
DOI: 10.1002/jps.2600680108
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Nonsteroidal Anti-Inflammatory and Other Pharmacological Agents on Tuberculin Reaction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1981
1981
2010
2010

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 55 publications
0
2
0
Order By: Relevance
“…However, it is well known that this test lacks sensitivity, especially in patients on dialysis, with reported anergy rates of up to 50% 20–23. Immunosuppressants used as treatment for kidney disease and in transplantation (including prednisolone, azathioprine, cyclophosphamide, ciclosporin, tacrolimus or mycophenolate mofetil and newer monocloncal antibodies) interfere with the accuracy of the TST 24. Chemoprophylaxis for LTBI itself carries a small risk of adverse events in patients with normal renal function, particularly of drug-induced hepatitis which increases with age and is occasionally fatal.…”
Section: Introductionmentioning
confidence: 99%
“…However, it is well known that this test lacks sensitivity, especially in patients on dialysis, with reported anergy rates of up to 50% 20–23. Immunosuppressants used as treatment for kidney disease and in transplantation (including prednisolone, azathioprine, cyclophosphamide, ciclosporin, tacrolimus or mycophenolate mofetil and newer monocloncal antibodies) interfere with the accuracy of the TST 24. Chemoprophylaxis for LTBI itself carries a small risk of adverse events in patients with normal renal function, particularly of drug-induced hepatitis which increases with age and is occasionally fatal.…”
Section: Introductionmentioning
confidence: 99%
“…20e23 Immunosuppressants used as treatment for kidney disease and in transplantation (including prednisolone, azathioprine, cyclophosphamide, ciclosporin, tacrolimus or mycophenolate mofetil and newer monocloncal antibodies) interfere with the accuracy of the TST. 24 Chemoprophylaxis for LTBI itself carries a small risk of adverse events in patients with normal renal function, particularly of druginduced hepatitis which increases with age and is occasionally fatal. There are no equivalent data for patients with CKD.…”
Section: Background 21 the Need For Recommendationsmentioning
confidence: 99%